Abstract:The epigenetic regulation of DNA-templated processes has been studied extensively during the last 15 years. As was revealed, DNA modification such as methylation possess great impact on cell fate and can result in abnormal protein expression patterns what can lead to the induction of carcinogenesis. DNA (cytosine-5)-methyltransferases are enzymes that catalyses the transfer of methyl groups to specific CpG structures in DNA. The methylation of these sequences can lead to inappropriate gene expression such as the silencing of tumor suppressor genes in cancer cells. DNA (cytosine-5)-methyltransferase 3A (DNMT3a) gene encodes a DNA methyltransferase that is thought to function mainly in de novo methylation. In the normal liver DNMT3a is usually expressed on the medium level, as was described in literature. Hepatocellular carcinoma (HCC) still remains one of the most common cause of death among patients with cancer. Fibrolamellar hepatocellular carcinoma (FL) represents rare subtype, which affects usually young people (an onset between 20-30 years) and its etiology is poorly understood. In our study we compared the presence of DNMT3a protein between two different types of HCC-common type and fibrolamellar one. We performed immunohistochemical staining of formalin fixed paraffin embedded tissue sections obtained from 30 patients (22 HCC and 8 FL). We found that DNMT3a immunoreactivity is significantly more pronounced in the non-fibrolamellar variant of HCC than in the fibrolamellar one. The DNMT3a immunoreactivity was predominantly localized in cancer cell nuclei in a form of separate large granules spotted in proximity to heterochromatin region. The reduced presence of DNMT3a in the fibrolamellar variant of HCC may suggest that different epigenetic mechanisms are involved in development of this particular type of liver cancer. Improving our understanding of the roles of DNMT proteins in hepatocarcinogenesis can benefit in the development of epigenetic –based therapy designed for specific HCC subtype.

Transcriptional and Post-Transcriptional Control of DNA Methyltransferase 3B is Regulated by Phosphatidylinositol 3 Kinase/akt Pathway in Human Hepatocellular Carcinoma Cell Lines.

ZNF191 Alters DNA Methylation and Activates the PI3K‐AKT Pathway in Hepatoma Cells Via Transcriptional Regulation of DNMT1

Identification of Potential Genes Regulated by DNA Methyltransferase 3B in a Hepatocellular Carcinoma Cell Line by RNA Interference and Microarray Analysis.

Phosphatidylinositol 3-kinase/protein kinase B pathway stabilizes DNA methyltransferase I protein and maintains DNA methylation.

Depletion of DNMT3A Suppressed Cell Proliferation and Restored PTEN in Hepatocellular Carcinoma Cell

Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma

Methyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2

Effect of Antisense DNMT3b Gene Eukaryotic Expression Plasmid on Expression of the DNMT3b Gene in Human Biliary Tract Carcinoma Cells.

Mechanistic And Biological Significance Of Dna Methyltransferase 1 Upregulated By Growth Factors In Human Hepatocellular Carcinoma

PIK3R3 is upregulated in liver cancer and activates Akt signaling to control cancer growth by regulation of CDKN1C and SMC1A

Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A

Upregulation of miR-137 Expression Suppresses Tumor Growth and Progression via Interacting with DNMT3a Through Inhibiting the PTEN/Akt Signaling in HCC

Expression of DNMT3B gene in hepatocellular carcinoma and its effect on proliferation, invasion and metastasis of hepatoma cells

Influence of DNA Methyltransferase 3b on the Expression of STAT1 and C-myc and the Methylation of Promoters in Human Hepatocellular Carcinolna Cell Line

DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation

Oncogenic DNA methyltransferase 1 activates the PI3K/AKT/mTOR signalling by blocking the binding of HSPB8 and BAG3 in melanoma

The Activation of Mtor Signalling Modulates DNA Methylation by Enhancing DNMT1 Translation in Hepatocellular Carcinoma.

Downregulation of MTHFD2 Inhibits Proliferation and Enhances Chemosensitivity in Hepatocellular Carcinoma via PI3K/AKT Pathway

The Expression of DNA Methyltransferase DNMT3a in Classical and Fibrolamellar Hepatocellular Carcinoma

Data from Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer

Protein Expression of Three DNA Methyltransferases in Hepatocellular Carcinoma and Its Clinical Significance